0
Book Reviews |

Aureomycin—A New Antibiotic.

Am J Dis Child. 1949;78(5):819. doi:10.1001/archpedi.1949.02030050836019.
Text Size: A A A
Published online

ABSTRACT

This is a collection of sixteen papers presented at a conference on aureomycin held by the Division of Mycology of the Section on Biology of the New York Academy of Sciences. The subject is covered intensively, from a general discussion of the discovery and source of aureomycin to the results of its use in various infections. The pharmacologic aspects and the toxicity of the drug are covered in detail, as are various bacteriologic studies in vitro and in vivo. Methods for determination of the antibiotic levels in body fluids are discussed.

Experimental work indicates that aureomycin is effective against a wide range of micro-organisms, including both bacilli and cocci. It appears also, on the basis of preliminary reports, to be highly effective against certain viral and rickettsial infections. Rocky Mountain spotted fever seems to be especially susceptible. California Q fever has responded promptly in a preliminary series of cases, and

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs